A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months
Clinical trial NCT07126262 · RECRUITING
Trial details
- NCT number
- NCT07126262
- Sponsor
- BioMarin Pharmaceutical
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-30
- Primary completion
- 2028-06-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.